CAPITAL IMPACT ADVISORS, LLC – Global Blood Therapeutics, Inc. Transaction History
CAPITAL IMPACT ADVISORS, LLC portfolio value:
$0
portfolio value
CAPITAL IMPACT ADVISORS, LLC quarter portfolio value change:
+113.15%
quarter
Global Blood Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -24.16K shares | -772K | $68.1 | 0 |
| Q2 2022 | share | Decrease | -16.67% | -4.83K shares | -233K | $31.95 | 24.16K |
| Q1 2022 | share | Increase | +29.12% | 6.54K shares | 348K | $34.64 | 29.00K |
| Q4 2021 | share | Increase | 0.00% | 22.46K shares | 657K | $29.86 | 22.46K |
| Q4 2020 | share | Decrease | -100.00% | -26.36K shares | -1.45M | $43.31 | 0 |
| Q3 2020 | share | Decrease | -15.94% | -5K shares | -526K | $55.14 | 26.36K |
| Q2 2020 | share | Decrease | -36.81% | -18.26K shares | -556K | $63.13 | 31.36K |
| Q1 2020 | share | Increase | +3.06% | 1.47K shares | -1.29M | $51.09 | 49.63K |
| Q4 2019 | share | 0.00% | 0 shares | 1.45M | $79.49 | 48.15K | |
| Q3 2019 | share | Increase | +20.79% | 8.28K shares | 222K | $48.52 | 48.15K |
| Q2 2019 | share | Decrease | -22.67% | -11.68K shares | 88K | $52.6 | 39.86K |
| Q1 2019 | share | 0.00% | 0 shares | 0 | $52.93 | 51.55K | |
| Q4 2018 | share | 0.00% | 0 shares | 97K | $41.05 | 51.55K | |
| Q3 2018 | share | Increase | +6.22% | 3.01K shares | -336K | $38 | 51.55K |
| Q2 2018 | share | Increase | +64.14% | 18.96K shares | 875K | $45.2 | 48.53K |
| Q1 2018 | share | Increase | 0.00% | 29.56K shares | 1.42M | $48.3 | 29.56K |